Pediatric Clinical Trials Market Share by Manufacturers 2028

Pediatric Clinical Trials Industry Overview

The global pediatric clinical trials market size was valued at USD 14.5 billion in 2021 and is anticipated to expand at a compound annual growth rate (CAGR) of 5.1% during the forecast period.

The global market has noticed critical growth on account of the rising R&D investments by pharmaceutical companies owing to the high burden of chronic and infectious diseases among the pediatrics. The COVID-19 pandemic has contributed significantly to the demand for pediatric clinical trials, owing to the growing demand for vaccines to curb the spread of the infection. For instance, In March 2021, the biotechnology company Moderna Inc. reported that it is recruiting patients aged between 6 -12 years for clinical trials of mRNA-1273 COVID-19 vaccines.

Gather more insights about the market drivers, restrains and growth of the Global Pediatric Clinical Trials Market

U.S. pediatric clinical trials market size, byphase, 2020-2030 (USD Billion)

Such factors are likely to have a positive impact on the market. Rising awareness among the parents for pediatric clinical trials for treating serious infections and chronic diseases, and a significant number of CROs conducting pediatric trials are also driving the market. Autism is one of the common disorders in children. As per the CDC, 1 in 44 children in the U.S. had autism in 2018. The high burden of autism among kinds is likely to drive the demand for autism clinical trials and thus is anticipated to promote market growth. Public organizations globally are providing funding to develop better treatment for the pediatric population.

For instance, in May 2022, the Australian Government’s Medical Research Future Fund (MRFF) funded USD 1.8 million to the researchers for developing a treatment for juvenile idiopathic arthritis. Such actions are further promoting the pediatric clinical trial market. Recruitment and patient retention are one of the major challenges for pediatric clinical research. However, in recent years there has been a gradual adoption of decentralized trials for easing the pediatric trials. For instance, in June 2021, a global organization, Clinical Oncology Group (COG) conducted clinical research for children and adolescents partnered with Signify Heath, a platform used for conducting decentralized trials.

This partnership was intended to conduct clinical trials for children suffering from leukemia. Such partnerships are likely to increase the adoption of decentralized trials and are expected to pediatric clinical trials faster. During the pandemic, pediatric clinical trials were halted to reduce the spread of the virus. This affected the recruitment of young patients for new trials. Such incidences are expected to have a negative impact on market growth. However, owing to the urgent need for advanced therapeutics many clinical trials were resumed. For instance, in August 2020, a biotech company, Cerecor Inc. resumed the Phase 1b clinical study of CERC-002 for treating severe pediatric-onset Crohn’s disease. Resuming clinical studies owing to the growing demand for innovative treatments has enhanced the market growth.

Browse through Grand View Research's Medical Devices Industry Research Reports.

  • Microcurrent Facial Market - The global microcurrent facial market size was estimated at USD 372.9 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 7.3% from 2023 to 2030.
  • Nebulizer Market - The global nebulizer market size was estimated at USD 1.07 billion in 2022 and is anticipated to expand at a compound annual growth rate (CAGR) of 5.9% from 2023 to 2030.

Market Share Insights

  • March 2022: Pfizer initiated a Phase 2/3 study for PAXLOVID tablets, specifically designed to treat COVID-19 in pediatric patients.
  • November 2018: A U.S.-based CRO, Synteract, acquired KinderPharm, a CRO focused on developing advanced therapies for pediatrics. This acquisition was intended to strengthen Synteract’s research activities in pediatric trials.

Key Companies profiled:

Some prominent players in the global pediatric clinical trials market include

  • ICON plc
  • Syneos Health
  • Medpace, Inc.
  • PPD Inc.
  • Premier Research
  • LabCorp Drug Development 
  • QPS Holdings.
  • Pfizer Inc.
  • The Emmes Company, LLC
  • IQVIA Inc.

Order a free sample PDF of the Pediatric Clinical Trials Market Intelligence Study, published by Grand View Research.

Comments

Popular posts from this blog

South Africa Veterinary Medicine Market Size, Share, Revenue Analysis By 2028

Fencing Market Competitive Landscape And Component Benchmarking 2030

U.S. Cold Storage Market Distributor Analysis and Forecasts By 2030